Evidence map›Paper›PMID 33080383›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.

Thibault Fiolet, Anthony Guihur, Mathieu Edouard Rebeaud, Matthieu Mulot, Nathan Peiffer-Smadja, Yahya Mahamat-Saleh

Abstract readLetter
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Current evidence on the use of anakinra in COVID-19.International immunopharmacology · 2022
    Review
  4. Article
  5. Review
  6. Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thibault FioletCESP (Centre for Research in Epidemiology and Population Health), Faculté de Médecine-Université Paris-Sud, Faculté de Médecine-UVSQ, INSERM, Université Paris Saclay, 94 805, Villejuif, France; Gustave Roussy, F-94805, Villejuif, France. Electronic address: Thibault.fiolet@gustaveroussy.fr.
Anthony GuihurDepartment of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
Mathieu Edouard RebeaudDepartment of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
Matthieu MulotLaboratory of Soil Biodiversity, Faculty of Science, University of Neuchâtel, Switzerland.
Nathan Peiffer-SmadjaUniversité de Paris, IAME, INSERM, F-75018 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, AP-HP, Paris, 75018, France.
Yahya Mahamat-SalehCESP (Centre for Research in Epidemiology and Population Health), Faculté de Médecine-Université Paris-Sud, Faculté de Médecine-UVSQ, INSERM, Université Paris Saclay, 94 805, Villejuif, France; Gustave Roussy, F-94805, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsAzithromycinChloroquineCOVID-19 Drug TreatmentHydroxychloroquineSARS-CoV-2COVID-19Drug Therapy, CombinationHumansMeta-Analysis as TopicSystematic Reviews as TopicTreatment OutcomeAntiviral AgentsAzithromycinChloroquineHydroxychloroquine

Identifiers

PMID33080383
PMCPMC7568487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.